The single-use therapeutic gastroscope is a newly approved disposable device designed for complex therapeutic interventions in gastrointestinal endoscopy. This pilot feasibility study assessed its clinical performance during 19 therapeutic procedures, including gastrointestinal bleeding management, pancreatic necrosectomies, foreign body removals, stent placements, and cryo-balloon ablations.
The single-use therapeutic gastroscope is a newly approved disposable device designed for complex therapeutic interventions in gastrointestinal endoscopy. This pilot feasibility study assessed its clinical performance during 19 therapeutic procedures, including gastrointestinal bleeding management, pancreatic necrosectomies, foreign body removals, stent placements, and cryo-balloon ablations. The device demonstrated an 84% intraprocedural technical success rate, with clinical success achieved universally when technical success was attained. However, in 16% of cases, clinicians had to switch to reusable gastroscopes due to limitations like poor visibility, suction occlusion, or inadequate scope angulation. User experience rated the device at 3.2 out of 5, reflecting moderate satisfaction. No adverse events were reported, indicating short-term safety. While the single-use gastroscope shows promise for therapeutic applications, its performance limitations and moderate usability suggest the need for further refinement. Broader studies are required to assess its long-term therapeutic reliability, visual performance, and environmental sustainability compared to reusable endoscopes.
Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...
Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...
Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...
Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...
Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...
Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.